Related Articles
Gefitinib‑induced interstitial pneumonia: A case report and review of the literature
Re-administration of gefitinib following diffuse interstitial lung disease in a patient with advanced lung adenocarcinoma: A case report and review of the literature
High efficacy of gefitinib in the treatment of EGFR mutation‑positive advanced non‑small cell lung adenocarcinoma: A case report
Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib‑associated leukocytoclastic vasculitis: A case report
The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting